Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.0481M
August 31, 2025 -0.0092M
May 31, 2025 0.0221M
February 28, 2025 -0.0163M
November 30, 2024 -0.0594M
August 31, 2024 0.061M
May 31, 2024 0.0264M
February 29, 2024 -0.1177M
November 30, 2023 -0.0819M
August 31, 2023 -0.1207M
May 31, 2023 -0.0234M
February 28, 2023 -0.0599M
November 30, 2022 -0.0192M
August 31, 2022 -0.0389M
May 31, 2022 -0.019M
February 28, 2022 -0.0374M
November 30, 2021 -0.0687M
August 31, 2021 -0.1252M
Date Value
May 31, 2021 -0.1571M
February 28, 2021 -0.1395M
November 30, 2020 -0.0829M
August 31, 2020 -0.1643M
May 31, 2020 -0.1304M
February 29, 2020 -0.2658M
November 30, 2019 -0.4069M
August 31, 2019 -0.5034M
May 31, 2019 -0.6259M
February 28, 2019 -0.9137M
November 30, 2018 -0.4996M
August 31, 2018 -0.4698M
May 31, 2018 -0.4556M
February 28, 2018 -0.0792M
November 30, 2017 -0.2613M
August 31, 2017 -0.4057M
May 31, 2017 -0.2061M
February 28, 2017 -0.2394M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 1.697M
Integrated BioPharma, Inc. -1.194M
BioForce Nanosciences Holdings, Inc. -0.027M
Skinvisible, Inc. 0.0022M
SkyTech Orion Global Corp. -0.16M

Cash from Operations (Quarterly) Related Metrics